SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-028232
Filing Date
2019-05-09
Accepted
2019-05-09 16:42:24
Documents
5
Period of Report
2019-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-9539_48k.htm 8-K 32499
2 EX-5.1 a19-9539_4ex5d1.htm EX-5.1 20289
3 EX-10.1 a19-9539_4ex10d1.htm EX-10.1 246102
4 GRAPHIC g95394kai001.jpg GRAPHIC 3585
5 GRAPHIC g95394kai002.jpg GRAPHIC 2124
  Complete submission text file 0001104659-19-028232.txt   308139
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37926 | Film No.: 19811280
SIC: 2834 Pharmaceutical Preparations